CN112481265B - Bacillus subtilis artificial terminator and application thereof - Google Patents
Bacillus subtilis artificial terminator and application thereof Download PDFInfo
- Publication number
- CN112481265B CN112481265B CN202011451933.4A CN202011451933A CN112481265B CN 112481265 B CN112481265 B CN 112481265B CN 202011451933 A CN202011451933 A CN 202011451933A CN 112481265 B CN112481265 B CN 112481265B
- Authority
- CN
- China
- Prior art keywords
- terminator
- gene
- terminators
- bacillus subtilis
- gfp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 244000063299 Bacillus subtilis Species 0.000 title claims abstract description 19
- 235000014469 Bacillus subtilis Nutrition 0.000 title claims abstract description 19
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 56
- 230000014509 gene expression Effects 0.000 claims abstract description 40
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 30
- 108090000790 Enzymes Proteins 0.000 claims abstract description 11
- 102000004190 Enzymes Human genes 0.000 claims abstract description 11
- 229940088598 enzyme Drugs 0.000 claims abstract description 11
- 108010073682 nattokinase Proteins 0.000 claims abstract description 9
- 229940086319 nattokinase Drugs 0.000 claims abstract description 6
- 241000894006 Bacteria Species 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 230000001105 regulatory effect Effects 0.000 claims description 7
- 235000013305 food Nutrition 0.000 claims description 4
- 239000013598 vector Substances 0.000 claims description 4
- 108090000856 Lyases Proteins 0.000 claims description 3
- 102000004317 Lyases Human genes 0.000 claims description 3
- 229940009098 aspartate Drugs 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 241000193830 Bacillus <bacterium> Species 0.000 claims 2
- 238000003889 chemical engineering Methods 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 238000011144 upstream manufacturing Methods 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 8
- 238000010353 genetic engineering Methods 0.000 abstract description 5
- 108010054624 red fluorescent protein Proteins 0.000 abstract description 4
- 108010043121 Green Fluorescent Proteins Proteins 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 108090000637 alpha-Amylases Proteins 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 description 34
- 239000005090 green fluorescent protein Substances 0.000 description 29
- 239000000243 solution Substances 0.000 description 16
- 239000002609 medium Substances 0.000 description 13
- 238000001712 DNA sequencing Methods 0.000 description 9
- 238000012512 characterization method Methods 0.000 description 9
- 238000001514 detection method Methods 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 7
- 241000276408 Bacillus subtilis subsp. subtilis str. 168 Species 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 108700016171 Aspartate ammonia-lyases Proteins 0.000 description 5
- 241001052560 Thallis Species 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000003259 recombinant expression Methods 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- 108010038447 Chromogranin A Proteins 0.000 description 3
- 102100031186 Chromogranin-A Human genes 0.000 description 3
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
- 241000588722 Escherichia Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 108700008625 Reporter Genes Proteins 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- CPTIBDHUFVHUJK-NZYDNVMFSA-N mitopodozide Chemical compound C1([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H](CO)[C@@H]2C(=O)NNCC)=CC(OC)=C(OC)C(OC)=C1 CPTIBDHUFVHUJK-NZYDNVMFSA-N 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 239000013605 shuttle vector Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 102100031746 Bone sialoprotein 2 Human genes 0.000 description 2
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 2
- 101000707248 Homo sapiens Bone sialoprotein 2 Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 108010007100 Pulmonary Surfactant-Associated Protein A Proteins 0.000 description 2
- 102100027773 Pulmonary surfactant-associated protein A2 Human genes 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- UFMQBWBQSCKRQH-UHFFFAOYSA-N 1-(1-aminoethoxy)ethanamine Chemical compound CC(N)OC(C)N UFMQBWBQSCKRQH-UHFFFAOYSA-N 0.000 description 1
- BDDLHHRCDSJVKV-UHFFFAOYSA-N 7028-40-2 Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O BDDLHHRCDSJVKV-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 229910052564 epsomite Inorganic materials 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 108091006047 fluorescent proteins Proteins 0.000 description 1
- 102000034287 fluorescent proteins Human genes 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960000999 sodium citrate dihydrate Drugs 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y403/00—Carbon-nitrogen lyases (4.3)
- C12Y403/01—Ammonia-lyases (4.3.1)
- C12Y403/01001—Aspartate ammonia-lyase (4.3.1.1), i.e. aspartase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/36—Vector systems having a special element relevant for transcription being a transcription termination element
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention discloses a bacillus subtilis artificial terminator and application thereof, belonging to the technical field of genetic engineering. The invention firstly characterizes the activity of different terminators, and then measures the termination efficiency of the terminators by using different terminator measuring platforms to obtain a series of novel terminators capable of improving the yield of target protein, wherein a green fluorescent protein gene is used as an upstream gene of the terminator, a red fluorescent protein gene is used as a downstream gene of the terminator, and the regulation level of the terminator on the upstream and downstream genes is characterized. The results show that these novel terminators are excellent in both the effect of increasing the expression level of the upstream gene and the effect of suppressing the expression level of the downstream gene. A series of different terminators are applied to the expression of recombinant proteins of nattokinase and pullulanase, and results show that the terminators are beneficial to improving the enzyme activity of the proteins and the protein expression level, so that the terminators have important application value in the production of target proteins in bacillus subtilis.
Description
Technical Field
The invention relates to a bacillus subtilis artificial terminator and application thereof, belonging to the technical field of genetic engineering.
Background
A transcription terminator is a sequence of RNA located downstream of a gene or operon and responsible for the dissociation of RNA polymerase and the release of transcribed RNA, which serves to terminate transcription. In prokaryotes, transcription terminators are of two types, one type being protein factor dependent, and need to function with the aid of protein factors, and consume ATP; the other is a hairpin structure which does not depend on any protein factors and only depends on the reverse palindrome of the hairpin structure and poly-U, also called an internal terminator. Transcription terminators are often located at the 3' end of genes due to their specific secondary structure and thus play an important role in maintaining the stability of mRNA and increasing the half-life of mRNA. The terminator is a substance that can separate RNA polymerase from the transcription complex, and can increase the efficiency of use of RNA polymerase and increase the expression level of the gene. Previously, the research on terminators has mainly focused on Escherichia coli, and only a small part of the literature mentions the use in other microorganisms, such as Saccharomyces cerevisiae, etc.
Bacillus subtilis is a production host widely used as food enzyme preparation and important nutritional chemicals. Therefore, the terminator which can regulate and control gene expression in the bacillus subtilis, is stable and high in activity has important application value for preparing target protein, especially protein used in the field of food, and therefore, how to obtain a high-efficiency, good-compatibility and protein expression-adjustable bacillus subtilis artificial terminator subsystem becomes a research hotspot.
Disclosure of Invention
In order to obtain a bacillus subtilis artificial terminator system which is efficient, good in compatibility and capable of regulating protein expression, the invention provides an element for regulating gene expression, wherein the element is a T5 terminator, a T24 terminator, a T31 terminator, a T42 terminator and a T52 terminator, and nucleotide sequences are respectively shown as SEQ ID No. 1-SEQ ID No. 5.
The application of the terminator in gene expression is that the terminator is placed at the downstream of a gene to be expressed and is co-expressed with the gene.
In one embodiment of the invention, the gene is a gene encoding nattokinase or a gene encoding aspartate lyase.
The invention also provides a vector containing the element.
The invention also provides a genetic engineering bacterium for expressing the vector.
The invention also provides a method for regulating and controlling the expression of the target protein in the bacillus subtilis, and the element and the target protein gene are co-expressed.
In one embodiment of the present invention, the Bacillus subtilis comprises Bacillus subtilis 168, bacillus subtilis WB400, bacillus subtilis WB600 or Bacillus subtilis WB800.
In one embodiment of the invention, the protein of interest comprises an enzyme.
The invention also provides application of the regulatory element or the genetic engineering bacteria in preparation of target protein.
The invention also provides the application of the regulatory element or the genetic engineering bacteria in the fields of food, pharmacy or chemical industry.
Advantageous effects
The invention firstly characterizes the activity of a single terminator, and finds that the expression quantity of upstream GFP is improved by 1.98 times and the expression quantity of downstream mcherry is reduced by 33.8 times when the T31 terminator is added compared with the case of not adding the terminator. And taking the green fluorescent protein gene as an upstream gene of the terminator, taking the red fluorescent protein gene as a downstream gene of the terminator, and representing the regulation level of the terminator on the upstream and downstream genes. The results show that the terminators have good effect on inhibiting the downstream gene expression level, for example, when the T42 terminator with the lowest termination efficiency is added, the downstream mCherry expression level is reduced by 1.43 times compared with the control. The terminator of the invention is put in different gene environments, the measured termination efficiency is almost unchanged, and the aim of inhibiting the expression quantity of downstream genes can be achieved. The target proteins with different expression amounts are obtained by taking terminators with different termination strengths as 3' end elements of gene expression, which has important application value for producing the target proteins in bacillus subtilis.
Drawings
FIG. 1: characterization of terminator termination efficiency, wherein G-mch-5, G-mch-24, G-mch-31, G-mch-42, and G-mch-52 respectively represent termination efficiencies of each terminator determined after insertion of the terminators T5, T24, T31, T42, and T52 between GFP and mcherry of plasmid pBp-GFP-mcherry.
FIG. 2: characterization of terminator termination efficiency reporter gene expression levels, where M: protein molecular weight standards; g-mch-0: no terminator is added; G-mch-5,G-mch-24, G-mch-31, G-mch-42, G-mch-52 respectively represent the expression levels of upstream and downstream proteins measured in the respective elements after insertion of terminators T5, T24, T31, T42, and T52 between GFP and mcherry of plasmid pBp-GFP-mcherry.
FIG. 3: characterization of fluorescence intensity of GFP upstream of the terminator, wherein control represents the reference plasmid, and G-mch-5, G-mch-24, G-mch-31, G-mch-42, and G-mch-52 represent the fluorescence intensity of GFP upstream of each terminator measured after insertion of the terminators T5, T24, T31, T42, and T52 between GFP and mcherry of the plasmid pBp-GFP-mcherry, respectively.
FIG. 4: characterization of the fluorescence intensity of the mCherry downstream of the terminator, wherein control represents the reference plasmid, and G-mch-5, G-mch-24, G-mch-31, G-mch-42, and G-mch-52 represent the fluorescence intensity of the mChery downstream of each terminator measured after insertion of the terminators T5, T24, T31, T42, and T52 between GFP and mChery of the plasmid pBp-GFP-mChery, respectively.
FIG. 5 is a schematic view of: verification of terminator element compatibility, wherein inRBS-5, inRBS-24, inRBS-31, inRBS-42 and inRBS-52 respectively represent the termination efficiency of each terminator measured after inserting the terminators T5, T24, T31, T42 and T52 between GFP and mcherry of plasmid pBp-GFP-ins-mcherry.
FIG. 6: characterization of terminator termination efficiency reporter gene expression levels, where M: protein molecular weight standards; inRBS-0: no terminator is added; inRBS-5, inRBS-24, inRBS-31, inRBS-42 and inRBS-52 respectively represent the expression levels of upstream and downstream proteins measured in different elements after inserting terminators T5, T24, T31, T42 and T52 between GFP and mcherry of plasmids pBp-GFP-ins-mcherry.
FIG. 7: characterization of fluorescence intensity of GFP upstream of terminator, wherein control represents the reference plasmid, and inRBS-5, inRBS-24, inRBS-31, inRBS-42 and inRBS-52 represent the fluorescence intensity of GFP upstream of each terminator measured after inserting the terminators T5, T24, T31, T42 and T52 between GFP and mcherry of the plasmid pBp-GFP-ins-mcherry, respectively.
FIG. 8: characterization of the fluorescence intensity of mCherry downstream of the terminator, wherein control represents the reference plasmid, wherein inRBS-5, inRBS-24, inRBS-31, inRBS-42 and inRBS-52 represent the fluorescence intensity of mChery downstream of each terminator measured after inserting the terminators T5, T24, T31, T42 and T52 between GFP and mChery of the plasmid pBp-GFP-ins-mChery, respectively.
FIG. 9: the terminator is used for characterization of the expression quantity of the nattokinase, wherein M: protein molecular weight standards; NK-0: no terminator is added; NK-5, NK-24, NK-31, NK-42 and NK-52 represent the expression levels of nattokinase upstream of each terminator measured after addition of terminators T5, T24, T31, T42 and T52 to the 3' -end of the nattokinase gene, respectively.
FIG. 10: the terminator is used for characterization of the expression amount of the aspartase, wherein M: protein molecular weight standards; aspA-0: no terminator is added; aspA-5, aspA-24, aspA-31, aspA-42 and AspA-52 respectively represent the amount of aspartase expression upstream of each terminator, which was measured after addition of the terminators T5, T24, T31, T42 and T52 to the 3' -end of the aspartase gene.
Detailed Description
The following examples relate to the following media:
Luria-Bertani (LB) liquid medium: 10g/L peptone, 5g/L yeast extract, 10g/L NaCl, pH 7.0.LB solid medium: 1.5% agar powder was added to the LB liquid medium.
Terrific-Broth (TB) medium 12g/L peptone, 24g/L yeast extract, 4g/L NaCl,17mM KH2PO4,72mM K2HPO4,pH 7.0。
SP I medium (20 mL): 9.8mL of SP-A solution, 9.8mL of SP-B solution, 200. Mu.L of 50% glucose solution, and 200. Mu.L of 100 XCAYE solution, which were mixed as they are.
SP II medium (6 mL): 5.88mL SPi medium, 60 μ L50 mM CaCl2Solution, 60. Mu.L of 250mM MgCl2 solution, ready to use mixed.
SP-A solution: 4g/L (NH)4)2SO4,28g/L K2HPO4·3H2O,12g/L KH2PO42g/L of sodium citrate dihydrate.
SP-B solution: 0.4g/L MgSO4·7H2O。
100 × CAYE solution: 20g/L Casamino acid,100g/L Yeast Extract.
100 × EGTA solution: 3.8g/L ethylene glycol bis (2-aminoethyl ether) tetraacetic acid (EGTA).
LB liquid culture medium and LB solid culture medium containing 1.5% agar are used for screening, culturing and characterizing thalli. TB medium was used for secretory expression of NK.
The transformation method of Bacillus subtilis 168 involved in the following examples was as follows:
selecting a single colony of bacillus subtilis 168, inoculating the single colony into 2mL of SP I culture medium, and performing shake culture at 37 ℃ for 12-14h to obtain a seed solution; inoculating the seed solution into 5mL SP I medium according to the inoculation amount of 1% (v/v), performing shake culture at 37 deg.C for 4-5h, and measuring OD600. When OD is reached600When the inoculation amount is 1.0 percent, transferring the bacterial liquid into 2mL of SP II culture medium according to the inoculation amount of 1 percent (v/v), and incubating for 1.5 hours at 37 ℃ and in a shaking table at 200 rpm; adding 20 μ L of 100 XEGTA (ethylene glycol bis (alpha-aminoethyl ether) tetraacetic acid) solution into the tube, culturing in a shaker at 37 deg.C and 200r/min for 10min, and subpackaging with 500 μ L per 1.5mL centrifuge tube; adding proper plasmid which is verified to be correct through sequencing into the tube, uniformly blowing, sucking and placing in a shaking table at 37 ℃ and 200r/min for culturing for 2h; after the culture is finished, sucking 100 mu L of bacterial liquid, uniformly coating the bacterial liquid on a corresponding selective plate, and culturing at 37 ℃ overnight for 12-14h.
The detection methods referred to in the following examples:
fluorescence detection of green fluorescent protein GFP:
centrifuging a detection sample at 12000r/min for 5min, collecting thalli, washing with PBS buffer solution for 3 times, finally resuspending the bacteria solution with the PBS buffer solution with the same volume, taking 200 mu L to a 96-hole enzyme label plate, and placing the plate into a Synergy TM H4 fluorescence enzyme label instrument to detect fluorescence. The program is set as follows: detecting the concentration of the thallus at 600 nm; excitation at 495nm, emission at 525nm, gain at 60, and fluorescence intensity measured.
And (3) detecting red fluorescent protein mchery fluorescence:
centrifuging a red fluorescent protein mcherry fluorescence detection sample at 12 000rpm for 5min, collecting thalli, washing the thalli for 3 times by PBS buffer solution, using PBS suspension thalli with the same volume, taking 200 mu L to a 96-hole enzyme label plate, and placing the enzyme label plate into a Synergy TM H4 fluorescence enzyme label instrument to detect fluorescence. The program is set as follows: detecting the concentration of the thallus at 600 nm; excitation light 587nm, emission light 610nm, gain 80, detection of fluorescence intensity.
Termination efficiency measurement method:
here we quantify the proportion of the transcriptional extension complex that does not pass through the terminator element by the Termination Efficiency (TE). The TE value of the terminator element which disrupts all the arriving transcription complexes is 100. The TE of the spacer sequences for GFP and mCherry is 0. Because the protein level of the expressed fluorescent reporter gene cannot be directly used to measure the TE value. We used downstream mcherry (FI)DW) And upstream GFP (FI)UP) The ratio of fluorescence of (A) to (B) to estimate the terminator read-Through (TR). Namely TR = FIDW/FIUP. Reference readthrough values (TR) were established using standardized test sequences (i.e., GFP and mCherry spacer sequences)REF) Then all TR measurements are normalized: TR (transmitter-receiver)NORM=TR/TRREFAnd estimating the termination efficiency by TE =100 × (1-TR)NORM)。
SDS-PAGE detection method:
taking out the preserved glycerol strain, streaking to a TB solid plate, culturing at 37 ℃ overnight, picking out a single colony to a test tube, and culturing at 37 ℃ for 8-10 h. According to the initial cell density OD600=0.05 inoculation into 250mL Erlenmeyer flask containing 50mL TB medium, culture at 37 ℃,200r/min for 24h.
SDS-PAGE detection of Nattokinase:
sucking fermentation liquor (1mL), centrifuging at 12000r/min for 2min, sucking 200 μ L supernatant, adding 50 μ L5 × Loading buffer, boiling water bath for 10min, and Loading for detection.
SDS-PAGE detection of aspartate lyase:
taking out the culture solution from the culture medium by 1mL, centrifuging at 12000r/min for 2min, collecting thallus, washing with 1 XPBS buffer solution for 3 times, adding TE buffer solution containing 1mg/mL lysozyme for suspension, and bathing at 37 deg.C for 2h. And (4) carrying out ultrasonic crushing for 3s and 2s until the bacterial suspension is clear and transparent. Centrifuging at 12000r/min for 20min, collecting 200 μ L supernatant, adding 50 μ L5 × Loading buffer, boiling water bath for 10min, and detecting.
Example 1: construction of terminator plasmid and recombinant expression of fluorescent protein
The method comprises the following specific steps:
(1) A pBp-GFP-mcherry (G-mch) plasmid is used as a template (the construction method is disclosed in the patent application with the publication number of CN 111662906A), a whole plasmid PCR is carried out by using a primer insulator-F/R synthesized by the company, a spacer sequence (the sequence is AATTAACAACTGATTCTGAATTCAAAAAATATCATTTGTGATTTGTTTAAAGAAAACGATTTAAAAATTTAAAA) is inserted between GFP and mcherry genes, and the whole plasmid PCR is carried out by using the primer insulator-F/R, so that a reference plasmid-pBp-GFP-inRBS-mcherry (abbreviated as inRBS) for determining the termination efficiency of a new terminator is obtained.
(2) Annealing the synthesized primer sequence with the enzyme cutting site by temperature gradient to form a double strand, then connecting the annealed DNA double strand sequence with a reference plasmid pBp-GFP-inRBS-mchery by BamH I and SacII enzyme-cut fragment by T4 ligase to construct a plasmid carrying terminators T5, T24, T31, T42 or T52 (shown in table 2), and performing DNA sequencing, wherein the DNA sequencing result shows that the terminators are successfully connected to the enzyme cutting site between GFP and mchery of plasmids pBp-GFP-mchery and pBp-GFP-inRBS-mchery, thereby proving that a new shuttle vector of Escherichia coli-Bacillus subtilis is successfully constructed; obtaining recombinant plasmids respectively: pBp43-GFP-T5-mcherry, pBp43-GFP-T24-mcherry, pBp43-GFP-T31-mcherry, pBp43-GFP-T42-mcherry, pBp43-GFP-T52-mcherry; pBp43-GFP-T5-inRBS-mcherry, pBp43-GFP-T24-inRBS-mcherry, pBp43-GFP-T31-inRBS-mcherry, pBp43-GFP-T42-inRBS-mcherry, and pBp43-GFP-T52-inRBS-mcherry.
(3) Transferring the obtained recombinant plasmid with correct sequencing verification into bacillus subtilis 168, performing static culture at 37 ℃ for 12-14h, then selecting a single colony to be cultured in 5mL of LB seed culture medium at 37 ℃; transfer to 250mL Erlenmeyer flasks containing 50mL LB medium at 200r/min, 37 ℃ for 24h at final OD600= 0.05.
In the termination efficiency assay platform G-mch, the termination efficiency (FIG. 1 and Table 3), SDS-PAGE protein gel assay (FIG. 2) and fluorescence intensity (FIG. 3, FIG. 4; table 4, table 5) of the selected terminators were determined, indicating that there was a difference in the expression levels of GFP and mcherry for the different terminators, indicating that the different terminators had different characteristics. The termination efficiency of the terminators T42, T52, T5, T24 and T31 is gradually increased, wherein the upstream GFP expression level is increased by 1.98 times and the downstream mcherry expression level is decreased by 33.9 times when the T31 terminator is added compared with the case that the terminator is not added;
in the termination efficiency assay platform inRBS, the termination efficiency (FIG. 5 and Table 6), SDS-PAGE protein gel assay (FIG. 6) and fluorescence intensity (FIG. 7, FIG. 8; table 7, table 8) of the selected terminators were determined to be consistent with those detected in the G-mch platform: wherein, when the T31 terminator is added, the upstream GFP expression level is increased by 3 times and the downstream mcherry expression level is decreased by 50 times compared with the case of not adding the terminator. Compared with the control, the protein expression of downstream mcherry is reduced along with the increase of the terminator termination efficiency, and the protein expression is consistent with the fluorescence measurement value.
This experiment shows that five terminators have strong compatibility.
TABLE 1 primer Table
TABLE 2 terminator sequences
TABLE 3 terminator termination efficiency (G-mch)
Terminator name | Terminating Efficiency (TE) |
T5 | 85.09 |
T24 | 90.90 |
T31 | 98.42 |
T42 | 43.33 |
T52 | 58.07 |
TABLE 4 fluorescence intensity of GFP upstream of terminator (G-mch)
Terminator name | Upstream GFP fluorescence intensity (FT)GFP/OD600) |
Comparison (G-mch) | 10225 |
T5 | 18047 |
T24 | 19032 |
T31 | 20214 |
T42 | 13400 |
T52 | 17193 |
TABLE 5 luminescence intensity of mCherry downstream of terminator (G-mch)
TABLE 6 terminator termination efficiency (inRBS)
Terminator name | Termination Efficiency (TE) |
T5 | 88.87 |
T24 | 92.46 |
T31 | 99.34 |
T42 | 48.71 |
T52 | 72.69 |
TABLE 7 terminator upstream GFP fluorescence intensity (inRBS)
Terminator name | Upstream GFP fluorescence intensity (FT)GFP/OD600) |
Control (inRBS) | 6533 |
T5 | 14350 |
T24 | 15294 |
T31 | 19658 |
T42 | 9346 |
T52 | 11643 |
TABLE 8 terminator downstream mCherry fluorescence intensity (inRBS)
Terminator name | Downstream mcherry fluorescence intensity (FT)mcherry/OD600) |
Control (inRBS) | 14621 |
T5 | 3943 |
T24 | 2600 |
T31 | 292 |
T42 | 10770 |
T52 | 6988 |
Example 2: construction of nattokinase protein recombinant expression system by using terminator
(1) The primer sequences were synthesized by the company (see Table 9).
(2) Constructing a nattokinase protein recombinant expression system: taking PBP43-GFP-mcherry as a template, using a primer temp-NK-F/R, and carrying out PCR amplification to obtain a framework; obtaining a PUT segment by a PCR amplification method by taking pBS04-pro-NK as a template and NK-F/R as a primer; and carrying out double-fragment assembly (infusion assembly) on the fragment NK and the skeleton, then transforming JM109, finally obtaining a new plasmid and carrying out DNA sequencing, wherein the DNA sequencing result shows that the plasmid PBP43-NK-0term (not connected with the terminator of the invention) is successfully obtained, and the new Escherichia coli-Bacillus subtilis shuttle vector is successfully constructed.
(3) Using PBP43-NK-0term as a template and primers with different terminators, see Table 1, plasmids were obtained by whole plasmid PCR and DNA sequencing, which indicated successful results of plasmid PBP43-NK-5term, PBP43-NK-24term, PBP43-NK-31term, PBP43-NK-42term, PBP43-NK-52term.
(4) Transferring the obtained recombinant plasmid with correct sequencing verification into bacillus subtilis 168, performing static culture at 37 ℃ for 12-14h, then selecting a single colony to be cultured in 5mL of TB seed culture medium at 37 ℃; according to the initial cell density OD600=0.05 transfer to 250mL Erlenmeyer flask containing 50mL TB medium, 200r/min, temperature 37 ℃, culture 24h.
(5) Taking the supernatant of the fermentation broth, and verifying the expression amount by SDS-PAGE (see FIG. 9); the expression level of NK-24 and NK-42 with addition of the terminator was slightly increased as compared with that without addition of the terminator.
TABLE 9 terminator primers Table
Example 3: construction of aspartase recombinant expression System Using terminator
(1) The primer sequences were synthesized by the company (see Table 9).
(2) Construction of the recombinant expression system for aspartase: taking PBP43-GFP-mcherry as a template, and obtaining a framework through PCR amplification by using a primer AspA-v-F/R; the AspA fragment is obtained by a PCR amplification method by taking pBp-ECAspA as a template and AspA-i-F/R as a primer. And carrying out double-fragment assembly (infusion assembly) on the fragment AspA and the skeleton, then transforming JM109, finally obtaining a new plasmid and carrying out DNA sequencing, wherein the DNA sequencing result shows that the plasmid PBP43-AspA-0term (not connected with the terminator of the invention) is successfully obtained, and the new Escherichia coli-Bacillus subtilis shuttle vector is successfully constructed.
(3) Plasmid was obtained by whole plasmid PCR using PBP43-AspA-0term as a template and primers with different terminators and DNA sequencing, and the results of DNA sequencing showed that plasmids PBP43-AspA-5term, PBP43-AspA-24term, PBP43-AspA-31term, PBP43-AspA-42term, PBP43-AspA-52term were successfully obtained.
(4) Transferring the obtained recombinant plasmid with correct sequencing verification into bacillus subtilis 168, performing static culture at 37 ℃ for 12-14h, then selecting a single colony to be cultured in 5mL of TB seed culture medium at 37 ℃; according to the initial cell density OD600=0.05 transfer to 250mL Erlenmeyer flask containing 50mL TB medium, 200r/min, temperature 37 ℃, culture 24h.
(5) Taking a certain amount of fermentation liquor, and verifying the expression quantity by SDS-PAGE (see figure 10); compared with AspA-0 without the terminator, the expression levels of AspA-5 and AspA-31 are obviously improved, and are about 2-3 times.
Although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
SEQUENCE LISTING
<110> university of south of the Yangtze river
<120> bacillus subtilis artificial terminator and application thereof
<130> BAA201240A
<160> 5
<170> PatentIn version 3.3
<210> 1
<211> 55
<212> DNA
<213> Artificial sequence
<400> 1
aaaaagagga gtagtgcctg agcagaggca ctaactcctc ttttgtcaat aacca 55
<210> 2
<211> 44
<212> DNA
<213> Artificial sequence
<400> 2
tgaaacagcc ctttctacgg gaagggctgt ttatattggg atgc 44
<210> 3
<211> 44
<212> DNA
<213> Artificial sequence
<400> 3
aaaaagactc cgtctaataa gacggagtct ttttttattt cgtt 44
<210> 4
<211> 41
<212> DNA
<213> Artificial sequence
<400> 4
agacgcggcc ggagtgcatc cggccgttct attgactaaa a 41
<210> 5
<211> 42
<212> DNA
<213> Artificial sequence
<400> 5
gcgaacaggg cttttttaga agccctgttt ttttattttt ct 42
Claims (10)
1. An element for regulating gene expression, which is characterized in that the element is a T5 terminator, and the nucleotide sequence is shown as SEQ ID NO. 1.
2. Use of a terminator as claimed in claim 1 for gene expression, wherein the terminator is placed downstream of the gene to be expressed and co-expressed with the gene.
3. Use according to claim 2, wherein the gene is a gene encoding nattokinase or a gene encoding aspartate lyase.
4. A vector comprising the element of claim 1.
5. A genetically engineered bacterium expressing the vector of claim 4.
6. A method for regulating the expression of a target protein in Bacillus subtilis, wherein the element of claim 1 is co-expressed with a target protein gene.
7. The method of claim 6, wherein the Bacillus subtilis is Bacillus subtilisBacillus subtilis 168、Bacillus subtilis WB400、Bacillus subtilisWB600 orBacillus subtilis WB800。
8. The method of claim 6 or 7, wherein the protein of interest is an enzyme.
9. Use of the element of claim 1 or the genetically engineered bacterium of claim 5 in the preparation of a protein of interest.
10. Use of the element of claim 1 or the genetically engineered bacterium of claim 5 in the fields of food, pharmaceutical or chemical engineering.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211197736.3A CN116622702A (en) | 2020-12-09 | 2020-12-09 | Novel artificially designed bacillus subtilis terminator and application thereof |
CN202211197866.7A CN116286814A (en) | 2020-12-09 | 2020-12-09 | Efficient artificial terminator for bacillus subtilis and application thereof |
CN202011451933.4A CN112481265B (en) | 2020-12-09 | 2020-12-09 | Bacillus subtilis artificial terminator and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011451933.4A CN112481265B (en) | 2020-12-09 | 2020-12-09 | Bacillus subtilis artificial terminator and application thereof |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211197736.3A Division CN116622702A (en) | 2020-12-09 | 2020-12-09 | Novel artificially designed bacillus subtilis terminator and application thereof |
CN202211197866.7A Division CN116286814A (en) | 2020-12-09 | 2020-12-09 | Efficient artificial terminator for bacillus subtilis and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112481265A CN112481265A (en) | 2021-03-12 |
CN112481265B true CN112481265B (en) | 2022-11-01 |
Family
ID=74941755
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211197736.3A Pending CN116622702A (en) | 2020-12-09 | 2020-12-09 | Novel artificially designed bacillus subtilis terminator and application thereof |
CN202011451933.4A Active CN112481265B (en) | 2020-12-09 | 2020-12-09 | Bacillus subtilis artificial terminator and application thereof |
CN202211197866.7A Pending CN116286814A (en) | 2020-12-09 | 2020-12-09 | Efficient artificial terminator for bacillus subtilis and application thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211197736.3A Pending CN116622702A (en) | 2020-12-09 | 2020-12-09 | Novel artificially designed bacillus subtilis terminator and application thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211197866.7A Pending CN116286814A (en) | 2020-12-09 | 2020-12-09 | Efficient artificial terminator for bacillus subtilis and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (3) | CN116622702A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113957072B (en) * | 2021-10-09 | 2023-06-27 | 湖北大学 | Short terminator suitable for bacillus licheniformis and application of short terminator in efficient expression of target product |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107012161A (en) * | 2017-04-03 | 2017-08-04 | 天津大学 | Corynebacterium glutamicum and structure and application using stalk hydrolyzate high yield butanedioic acid |
CN111718934A (en) * | 2018-12-18 | 2020-09-29 | 江南大学 | Novel terminator and application thereof |
-
2020
- 2020-12-09 CN CN202211197736.3A patent/CN116622702A/en active Pending
- 2020-12-09 CN CN202011451933.4A patent/CN112481265B/en active Active
- 2020-12-09 CN CN202211197866.7A patent/CN116286814A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107012161A (en) * | 2017-04-03 | 2017-08-04 | 天津大学 | Corynebacterium glutamicum and structure and application using stalk hydrolyzate high yield butanedioic acid |
CN111718934A (en) * | 2018-12-18 | 2020-09-29 | 江南大学 | Novel terminator and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN112481265A (en) | 2021-03-12 |
CN116622702A (en) | 2023-08-22 |
CN116286814A (en) | 2023-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112501193B (en) | Nicotinic acid and nicotinamide biosensing system | |
CN103911371B (en) | The integrated expression vector of a kind of saccharomyces cerevisiae | |
CN112481265B (en) | Bacillus subtilis artificial terminator and application thereof | |
CN110551749A (en) | Construction method and application of pseudomonas putida suicide vector | |
Pablos et al. | Vitreoscilla hemoglobin expression in engineered Escherichia coli: Improved performance in high cell‐density batch cultivations | |
CN104480130A (en) | PTerm-SC plasmid as well as construction method and application thereof | |
CN113073108B (en) | Quorum sensing type bidirectional regulation and control system and application thereof | |
CN108220322B (en) | DNA for improving expression quantity of bacillus subtilis protein | |
CN106701787A (en) | Pichia pastoris for expressing foreign proteins, construction method of pichia pastoris and induced expression method of pichia pastoris | |
CN109852650B (en) | Artificial aptamer enzyme regulated and controlled by theophylline and application | |
CN111662906B (en) | Novel terminator and application thereof | |
CN113957072B (en) | Short terminator suitable for bacillus licheniformis and application of short terminator in efficient expression of target product | |
CN108866057B (en) | Escherichia coli pressure response type promoter and preparation method thereof | |
CN114672449A (en) | Strain for efficiently expressing lactoferrin by using temperature-sensitive promoter as well as construction method and application of strain | |
CN102892884B (en) | Method for producing kluyveromyces marxianus transformant | |
CN109321618A (en) | A method of yield of erythrocin is improved by the red mould SACE_5717 gene of the more spores of sugar | |
CN112359007B (en) | Exogenous introduction edd gene bacillus licheniformis for producing bacitracin and application | |
CN110777104B (en) | Construction method of xanthan gum high-yield strain | |
CN113106095A (en) | Sequence for increasing gram-positive bacteria translation initiation site and application thereof in improving protein expression efficiency | |
CN103917648A (en) | Cassettes and methods for transforming and selecting yeast transformants by homologous recombination | |
CN104513830A (en) | Gene expression vector applicable to gluconobacter oxydans and application of gene expression vector | |
CN113736789B (en) | Application of N-terminal sequence element in regulation and control of saccharomyces cerevisiae protein expression | |
CN114480469B (en) | Gene editing carrier loading tuckahoe endogenous sequence, editing system and application | |
CN113061642B (en) | Application of high-throughput screening construction of glycollic acid high-yield bacteria by utilizing biosensor | |
CN114107309B (en) | Non-natural theophylline RNA molecular switch |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |